j a 4 0c “ ion of a Sciences (ns) iety (AMS) I10.00-10.30 10.30-11.00 _ Moderator: 11.00-1 1.20 11.20-1 1.40 11.40-12.00 12.00-12.20 Scientific Committee Crommelin Daan latrou Christos Macheras Panos Shah Vinod Scientific Program Welcome message by Panos Macheras, Professor of Pharmacy, National and Kapodistrian University of Athens, Greece Biotechnology Product Development Panos Macheras What are biotechnology drugs? How are they different from other conventional drugs? Daan Crommelin, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, The Netherlands Global perspectives on biotechnology based therapeutic products Vinod Shah, Pharmaceutical Consultant Immunogenicity of biopharmaceuticals (Interferons and Erythopoetin) Hub Schellekens, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, The Netherlands PANEL DISCUSSION COFFEE BREAK Anthony Avgerinos Pharmacokinetics and Pharmacodynamics of therapeutic macromolecules Vangelis Karalis, Thriasio General Hospital of Elefsina, Greece The prerequisites for safe and efficacious biological medicinal products with a special reference to biosimilars Panos Macheras, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece Experience from the use of the Biotech products in the hospital Despina Makridaki, Sismanoglio General Hospital of Athens, Greece Role of hospital pharmacist in Individualized medicine Hitoshi Sasaki, Nagasaki University Hospital, Japan12.20-12.50 12.50-13.50 Session II: Moderator: 13.50-14.10 14.10-14.30 14.30-14.50 14.50-15.20 15.20-15.50 Moderator: 15.50-16.10 16.10-16.30 16.30-16.50 16.50-17.20 PANEL DISCUSSION LUNCH BREAK Evidence based medicine of biotech products in Clinical Pra Asterios Tsiftsoglou Sharing clinical experience in oncology Anastasios Boutis, 2nd General IKA Hospital of Thessaloniki, “Panagia”, Thessalonoki, Greece Novel drugs for the management of multiple myeloma Evangelos Terpos, University of Athens, Greece Novel Thrombopoietic Agents in Haematology. Clinical and Experimental Data t Helen Papadaki, University Hospital of Heraklion, Heraklion, Greed PANEL DISCUSSION COFFEE BREAK Christos latrou Bio-engineering of erythropoietin - the dawn of the biotechnology David Goldsmith, Renal and Transplantation Department, i Guy’s Hospital, London, UK Lysosomal Storage Disorders: enzyme replacement treatment of Fabry disease Konstantinos Siamopoulos, University Hospital of loannina, loannina, Greece Epitopes and complementary epitopes of autoantigens for the stud of the autoimmune response. Current status and future prospects Athanasios Tzioufas, Faculty of Medicine, National and Kapodistrian University of Athens, Greece PANEL DISCUSSIONDATES TO REMEMBER Deadline for Speakers’ Abstract Submission: May 28th, 2010 One day course date: July Ist, 2010 GENERAL INFORMATION © Location and Date: The Course will take place in Athens, the capital of Greece, on Thursday, the Ist of July 2010, at the University of Athens (Main building) @ Congress Venue: University of Athens (Main building) is located at 30, Panepisti- miou Str. in the heart of the Historical and Commercial centre, between Syntagma & Omonia, the city’s two major squares. © Official Language: The official language of the Congress will be English, however translation will be provided to the Greek language. e Entrance to the day course: Free admission. However, there will be limited seat availability. Please apply on time at the Congress Organizer as below, as registrations will be confirmed on a first come first served basis. © Weather Conditions: In July the average temperature in Athens ranges from 25 to 32 degrees Celsius. The weather is suitable for walking, sunbathing and swimming. @ Congress Website: The congress will be hosted by the following website and will be constantly updated with all important information. URL link: www.afea.gr CALL FOR ABSTRACTS Invited Speakers’ Abstacts should be received by May 28th, 2010. CONGRESS ORGANIZER AX AFEA AFEA S.A. Travel & Congress Services Professional Congress Organizer (PCO) Tel. +30 210 3668854, Fax. +30 210 3643511 Email: valasoglou@atea.gr www.afea.gr With the kind support of: AMGEN’ @ Smesmrcuc t NOVAK ™ The Congress Organiser, consistent withthe natural resources saving, printed this publication in paper derived from special management forestall resources and in strictly specified numberof copes, so there is no waste of paper.